Brainsway dTMS for Major Depressive Disorder (MDD)

BrainsWay’s patented Deep TMS treatment is an innovative and effective treatment option for depression. BrainsWay D is leading a new era in the treatment and research of brain disorders. It offers relief for many patients suffering from this life-altering condition.

Introducing BrainsWay D, a non-invasive and innovative treatment that is successfully transforming the lives of patients who are suffering from Major Depressive Disorder (MDD). 33% of MDD patients are resistant to any medication and 52% fail to respond to first-line therapy. The U.S. Food and Drug Administration (FDA) cleared BrainsWay’s Deep TMS device for the treatment of depression in patients who failed to respond to antidepressant medications. The treatment is well-tolerated and has been demonstrated to be effective in several clinical trials.*

BrainsWay D‘s unique, patented treatment method stimulates deep and broad neuronal targets. The treatment involves deep magnetic stimulation of the bilateral prefrontal cortex, which has been shown to be responsible for depression, and has been shown to significantly improve depression symptoms in many patients, leading to remission in about one third of patients.

Patients who have not seen improvement in their MDD symptoms using other forms of treatment may finally find relief with BrainsWay D. Deep TMS is a comfortable, non-invasive treatment option that does not require anesthesia or hospitalization. It carries no systemic side effects.